The effect of HLA matching on kidney-graft survival

1981 ◽  
Vol 2 (2) ◽  
pp. 25-29 ◽  
Author(s):  
Alan Ting
1990 ◽  
Vol 50 (1) ◽  
pp. 146-149 ◽  
Author(s):  
J. THOROGOOD ◽  
G. G. PERSIJN ◽  
G. M. TH. SCHREUDER ◽  
J. D. ‘AMARO ◽  
F. A. ZANTVOORT ◽  
...  

2021 ◽  
Vol 6 (4) ◽  
pp. S306
Author(s):  
S. AYED ◽  
M. Ben salem ◽  
M. Hammouda ◽  
A. Letaief ◽  
M. Ben salah ◽  
...  

2021 ◽  
Vol 10 (15) ◽  
pp. 3237
Author(s):  
Lukas Johannes Lehner ◽  
Robert Öllinger ◽  
Brigitta Globke ◽  
Marcel G. Naik ◽  
Klemens Budde ◽  
...  

(1) Background: Simultaneous pancreas–kidney transplantation (SPKT) is a standard therapeutic option for patients with diabetes mellitus type I and kidney failure. Early pancreas allograft failure is a complication potentially associated with worse outcomes. (2) Methods: We performed a landmark analysis to assess the impact of early pancreas graft loss within 3 months on mortality and kidney graft survival over 10 years. This retrospective single-center study included 114 adult patients who underwent an SPKT between 2005 and 2018. (3) Results: Pancreas graft survival rate was 85.1% at 3 months. The main causes of early pancreas graft loss were thrombosis (6.1%), necrosis (2.6%), and pancreatitis (2.6%). Early pancreas graft loss was not associated with reduced patient survival (p = 0.168) or major adverse cerebral or cardiovascular events over 10 years (p = 0.741) compared to patients with functioning pancreas, after 3 months. Moreover, kidney graft function (p = 0.494) and survival (p = 0.461) were not significantly influenced by early pancreas graft loss. (4) Conclusion: In this study, using the landmark analysis technique, early pancreas graft loss within 3 months did not significantly impact patient or kidney graft survival over 10 years.


1981 ◽  
Vol 18 (2) ◽  
pp. 101-104 ◽  
Author(s):  
Raynald Roy ◽  
Yves Fradet ◽  
Jean-Guy Lachance
Keyword(s):  

2016 ◽  
Vol 30 (6) ◽  
pp. 869-875 ◽  
Author(s):  
María A. Ballesteros ◽  
Jorge Duerto Álvarez ◽  
Luis Martín-Penagos ◽  
Emilio Rodrigo ◽  
Manuel Arias ◽  
...  

1995 ◽  
Vol 8 (5) ◽  
pp. 366-373 ◽  
Author(s):  
Henk H. Hartgrink ◽  
J. Hajo Bockel ◽  
Bettina Hansen ◽  
Jane Thorogood ◽  
Jo Hermans ◽  
...  

2008 ◽  
Vol 90 (3) ◽  
pp. 247-250 ◽  
Author(s):  
Nadeem Ahmad ◽  
Kamran Ahmed ◽  
Mohammad Shamim Khan ◽  
Francis Calder ◽  
Nizam Mamode ◽  
...  

INTRODUCTION An increasing number of living-unrelated, kidney donor transplants are being performed in our unit. We present a comparison of living-unrelated (LURD) and living-related donor (LRD) renal transplant outcomes and analyse influencing factors. PATIENTS AND METHODS We retrospectively analysed the outcome of all living-donor renal transplants performed at our centre from 1993 to 2004. The parameters studied included patient and graft survival, functioning status of grafts (determined by estimated GFR) at last follow-up and any rejection episodes. Multivariate analysis was performed for recipient and donor age, ethnicity, HLA matching and re-transplants. RESULTS A total of 322 live donor kidney transplants (LRD, n = 261; LURD, n = 61) were carried out over this period. Mean recipient age was 28 ± 16 years in the LRD group and 48 ± 12 years in LURD, while mean age of the donors was 43 ± 11 years and 48 ± 10 years, respectively. Caucasians constituted 80% of all the living donors. Amongst LRD, parents were the commonest (58%) donors followed by siblings (35%). In LURD, 80% were spouses. A total of 33 grafts failed, 30 in LRD (11%) and 3 in LURD (5%). Thirteen patients died, 11 (4.2%) in LRD (7 with functioning graft) and 2 (3.3%) in LURD (1 with functioning graft). Acute rejections occurred in 41% recipients in LRD and 35% in LURD (P = 0.37). Estimated GFR was lower in LURD than in LRD (49 ± 14 versus 59 ± 29 ml/min/1.73 m2; P = 0.032). One- and 3-year patient survival for LRD and LURD was 98.7% and 96.3% and 97.7% and 95%, respectively (P = 0.75). One- and 3-year graft survival was equivalent at 94.8% and 92.3% for LRD, and 98.4% and 93.7% for LURD, respectively (P = 0.18). CONCLUSIONS Outcome of LRD and LURD is comparable in terms of patient and graft survival, acute rejection rate and estimated GFR despite differences in demographics, HLA matching and re-transplants of recipients.


Sign in / Sign up

Export Citation Format

Share Document